Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 37.11 | -16.97 |
PEG Ratio (TTM) | 10.39 | -5.50 |
P/S Ratio (TTM) | N/A | 37.96 |
P/B Ratio (TTM) | 93.39 | 5.82 |
P/FCF Ratio (TTM) | -32.94 | -149.23 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 3.39% | 285.23% |
ROE (TTM) | 4.61% | -4,189.45% |
Net Profit Margin (TTM) | N/A | -1,011.92% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 5.47% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | 4.68% | N/A | N/A |
Cash Flow | -1,181.08% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.67 | 4.92 |
Quick Ratio (TTM) | 1.67 | 4.90 |
D/E Ratio (TTM) | N/A | 1.28 |
Interest Coverage (TTM) | N/A | -11.13 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 23.66 | 20.83 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.83% |